Bayer Q2 Pharma Sales Ravaged By COVID-19
Cancelled Appointments Hurt Eylea
Turnover at the German group's pharma unit has been hit harder than forecast by the coronavirus pandemic and hefty price cuts linked to China's drug procurement policy but Bayer remains upbeat.
